Literature DB >> 10894212

Effects of botulinum toxin type A on intracortical inhibition in patients with dystonia.

F Gilio1, A Currà, C Lorenzano, N Modugno, M Manfredi, A Berardelli.   

Abstract

To find out whether botulinum toxin alters the excitability of cortical motor areas, we studied intracortical inhibition with transcranial magnetic stimulation in patients with upper limb dystonia before, 1 month after, and 3 months after the injection of botulinum toxin type A in the affected muscles. Eleven normal subjects and 12 patients with dystonia involving the upper limbs (7 with generalized dystonia, 2 with segmental dystonia, and 3 with focal dystonia) were studied. Patients were assessed clinically with the Dystonia Movement Scale. Paired magnetic stimuli were delivered by two Magstim 200 magnetic stimulators connected through a Bistim module to a figure-of-eight coil placed over the motor area of the forearm muscles. Paired stimulation was given at rest. A subthreshold (80% of motor threshold) conditioning stimulus was delivered 3 and 5 msec before the suprathreshold (120% of motor threshold) test stimulus. Electromyographic signals were recorded over the flexor or extensor muscles of the forearm on the affected side. We measured the amplitude of the test motor evoked potential (expressed as a percentage of the unconditioned motor evoked potential). All results were compared using ANOVA. In all patients, a botulinum toxin type A injection (50-100 mouse units) reduced dystonic movements in the arm. In normal subjects, electromyographic recordings showed significant inhibition of the test response. Before botulinum toxin injection, patients had less test response inhibition than normal subjects. One month after injection, patients had test response inhibition similar to that of normal subjects. At 3 months after injection, they again had less inhibition than normal subjects or patients at 1 month after injection. In conclusion, our data suggest that botulinum toxin can transiently alter the excitability of the cortical motor areas by reorganizing the inhibitory and excitatory intracortical circuits. The cortical changes probably originate through peripheral mechanisms.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10894212

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  46 in total

1.  Impaired inhibition of a pre-planned response in focal hand dystonia.

Authors:  Cathy M Stinear; Winston D Byblow
Journal:  Exp Brain Res       Date:  2004-04-27       Impact factor: 1.972

Review 2.  Neurophysiological effects of botulinum toxin type A.

Authors:  G Abbruzzese; A Berardelli
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

Review 3.  Botulinum toxin for pain.

Authors:  Roberto Casale; Valeria Tugnoli
Journal:  Drugs R D       Date:  2008

Review 4.  Evidence for the effectiveness of botulinum toxin for writer's cramp.

Authors:  K Dashtipour; R A Pender
Journal:  J Neural Transm (Vienna)       Date:  2008-03-06       Impact factor: 3.575

Review 5.  Phenomenology, genetics, and CNS network abnormalities in laryngeal dystonia: A 30-year experience.

Authors:  Andrew Blitzer; Mitchell F Brin; Kristina Simonyan; Laurie J Ozelius; Steven J Frucht
Journal:  Laryngoscope       Date:  2017-12-08       Impact factor: 3.325

Review 6.  Treatment and physiology in Parkinson's disease and dystonia: using transcranial magnetic stimulation to uncover the mechanisms of action.

Authors:  Aparna Wagle Shukla; David E Vaillancourt
Journal:  Curr Neurol Neurosci Rep       Date:  2014-06       Impact factor: 5.081

7.  Effects of botulinum toxin type A on vibration induced facilitation of motor evoked potentials in spasmodic torticollis.

Authors:  P P Urban; R Rolke
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-11       Impact factor: 10.154

Review 8.  Task-specific dystonias: a review.

Authors:  Diego Torres-Russotto; Joel S Perlmutter
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

9.  Botulinum Toxin: Non-cosmetic Indications and Possible Mechanisms of Action.

Authors:  Uwe Wollina
Journal:  J Cutan Aesthet Surg       Date:  2008-01

10.  Unilateral versus bilateral thyroarytenoid Botulinum toxin injections in adductor spasmodic dysphonia: a prospective study.

Authors:  Tahwinder Upile; Behrad Elmiyeh; Waseem Jerjes; Vyas Prasad; Panagiotis Kafas; Jesuloba Abiola; Bryan Youl; Ruth Epstein; Colin Hopper; Holger Sudhoff; John Rubin
Journal:  Head Face Med       Date:  2009-10-24       Impact factor: 2.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.